Results 61 to 70 of about 289,502 (331)

Appreciation of the personalized BETER lifestyle intervention for overweight: a case series design [PDF]

open access: green, 2022
Iris M. Kanera   +4 more
openalex   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Biomarkers-based personalized follow-up in chronic  heart failure improves patient’s outcomes and reduces care associate cost. [PDF]

open access: gold, 2021
Antonio León‐Justel   +7 more
openalex   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

open access: yesMolecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié   +13 more
wiley   +1 more source

A Model for Personalized Keyword Extraction from Web Pages using Segmentation

open access: yes, 2012
The World Wide Web caters to the needs of billions of users in heterogeneous groups. Each user accessing the World Wide Web might have his / her own specific interest and would expect the web to respond to the specific requirements. The process of making
Aghila, G., Kuppusamy, K. S.
core   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Trust in the age of artificial intelligence: a framework for privacy protection in personalised marketing

open access: yesMednarodno Inovativno Poslovanje
Understanding the role of first-party data and AI is crucial in today’s personalized, data-driven economy. First-party data—collected directly from users with consent—enables effective personalization but also raises ethical and legal concerns.
Maja Gorjanc
doaj   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

open access: yesMolecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris   +10 more
wiley   +1 more source

Personalization as a key principle of adult learning in digitalization conditions

open access: yesВестник Мининского университета
Introduction. The article is devoted to the study of the principle of personalization and its application in the design of educational programs for adult learners.
E. O. Vorobchikova
doaj   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy